Aggressive pituitary tumors (APTs) and pituitary carcinomas (PCs) are heterogeneous with
regard to clinical presentation, proliferative markers, clinical course, and response to …

The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …

Pituitary tumors are not rare if prevalence rates from autopsy or radiological series are
considered; approximately 0.5% of all pituitary adenomas will come to medical attention …

Pituitary tumors (PTs) are a heterogeneous group of lesions of the central nervous system
that are usually benign. Most of them occur sporadically, but 5% can do so within family …

Pituitary carcinoma is a rare disease, defined by the presence of cerebrospinal or distant
metastasis of a pituitary neuroendocrine tumor (PitNET). To review our institutional …

Abstract Context The 2017 WHO Classification of Pituitary Tumors grades silent corticotroph
adenomas (SCAs) as “high-risk adenomas” due to their aggressive clinical behavior (high …

ABSTRACT Pituitary adenomas comprise approximately 10-20% of intracranial tumors. Non-
functioning pituitary adenomas (NFPAs) are benign adenohypophyseal tumors not …

Pituitary adenomas are unique in multiple ways. They are rarely malignant in terms of
metastases; yet, they may be aggressive. Their cancerous potential is defined in a classic …

The majority of anterior pituitary tumors behave benignly, that is, they grow slowly and do not
metastasize, and were therefore called adenomas. However, they would frequently invade …

The aim of the present study was to investigate the role and potential regulatory
mechanisms of cyclin B1 (CCNB1) in the proliferation, apoptosis and epithelial‑to …